AGIO
Agios Pharm
NASDAQ: AGIO · HEALTHCARE · BIOTECHNOLOGY
$28.05
+13.10% today
Updated 2026-04-29
Market cap
$1.67B
P/E ratio
—
P/S ratio
30.88x
EPS (TTM)
$-7.26
Dividend yield
—
52W range
$22 – $46
Volume
1.1M
Agios Pharm (AGIO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-609.00%
ROE
-30.20%
ROA
-19.90%
Debt/equity
0.03x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | $21.84M | $-23.71M | 100.00% | -76.16% | -108.56% |
| 2012 | $25.11M | $-20.10M | -63.45% | -91.59% | -80.07% |
| 2013 | $25.55M | $-39.41M | 100.00% | -152.20% | -154.25% |
| 2014 | $65.36M | $-53.50M | 100.00% | -82.83% | -81.86% |
| 2015 | $59.12M | $-117.73M | 100.00% | -200.78% | -199.14% |
| 2016 | $69.89M | $-198.47M | 100.00% | -287.57% | -283.97% |
| 2017 | $43.01M | $-314.67M | 100.00% | -745.84% | -731.60% |
| 2018 | $94.39M | $-346.03M | 98.52% | -384.03% | -366.61% |
| 2019 | $117.91M | $-411.47M | 98.88% | -361.57% | -348.97% |
| 2020 | $203.20M | $-327.37M | -9.24% | -165.32% | -161.11% |
| 2021 | $41409.00 | $1.60B | -45,345.21% | -913,854.48% | 3,875,280.74% |
| 2022 | $14.24M | $-231.80M | 88.03% | -2,732.07% | -1,627.82% |
| 2023 | $26.82M | $-352.09M | 64.57% | -1,459.52% | -1,312.63% |
| 2024 | $36.50M | $673.73M | 88.59% | -1,166.47% | 1,845.92% |
| 2025 | $54.03M | $-412.78M | 88.26% | -873.87% | -764.01% |